Recent Advances in Stage 4 Breast Cancer Treatment
The landscape of stage 4 breast cancer treatment is rapidly evolving, with several promising new therapies emerging. Here are some of the latest advancements
Targeted Therapies
- HER2-positive breast cancer:
- Trastuzumab deruxtecan (T-DXd): A novel antibody-drug conjugate approved for HER2-low breast cancer.It combines the targeting capabilities of trastuzumab with the potent chemotherapy drug deruxtecan.
- Enhertu (fam-trastuzumab deruxtecan): Another antibody-drug conjugate that has shown promising results for HER2-positive breast cancer.
- Hormone receptor-positive breast cancer:
- CDK4/6 inhibitors: These drugs target specific proteins that help cancer cells grow and divide. They’ve shown significant benefits for patients with HR-positive, HER2-negative breast cancer.
- Combining different treatments: On an ongoing basis we are exploring the potential benefits of combining various therapies, such as targeted therapies with immunotherapy or chemotherapy as effective stage 4 breast cancer treatments.
Stage 4 Breast Cancer Treatment
For more information, please refer to these reliable sources:
